Subcommittee F04.16 on Biocompatibility Test Methods


    Showing results 1-26 of 26 matching ACTIVE standards under the jurisdiction of F04.16     F04 Home

    E1262-88(2013) Standard Guide for Performance of Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay

    F619-14 Standard Practice for Extraction of Medical Plastics

    F719-81(2012) Standard Practice for Testing Biomaterials in Rabbits for Primary Skin Irritation

    F720-17 Standard Practice for Testing Guinea Pigs for Contact Allergens: Guinea Pig Maximization Test

        See also WK52319 proposed revision

    F748-16 Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices

    F749-13 Standard Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit

    F750-87(2012) Standard Practice for Evaluating Material Extracts by Systemic Injection in the Mouse

    F756-17 Standard Practice for Assessment of Hemolytic Properties of Materials

        See also WK13187 proposed revision

    F763-04(2016) Standard Practice for Short-Term Screening of Implant Materials

    F813-07(2012) Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices

    F895-11(2016) Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity

    F981-04(2016) Standard Practice for Assessment of Compatibility of Biomaterials for Surgical Implants with Respect to Effect of Materials on Muscle and Insertion into Bone

    F1027-86(2012) Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices

    F1408-97(2013) Standard Practice for Subcutaneous Screening Test for Implant Materials

    F1439-03(2013) Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials

    F1877-16 Standard Practice for Characterization of Particles

    F1903-10 Standard Practice for Testing For Biological Responses to Particles In Vitro

        See also WK54593 proposed revision

    F1904-14 Standard Practice for Testing the Biological Responses to Particles in vivo

    F1983-14 Standard Practice for Assessment of Selected Tissue Effects of Absorbable Biomaterials for Implant Applications

    F1984-99(2013) Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials

    F2147-01(2016) Standard Practice for Guinea Pig: Split Adjuvant and Closed Patch Testing for Contact Allergens

    F2148-13 Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)

    F2382-04(2010) Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT)

        See also WK52322 proposed revision

    F2808-10 Standard Test Method for Performing Behind-the-Knee (BTK) Test for Evaluating Skin Irritation Response to Products and Materials That Come Into Repeated or Extended Contact with Skin

        See also WK52333 proposed withdrawal

        See also WK57783 proposed revision

    F2888-13 Standard Test Method for Platelet Leukocyte Count—An In-Vitro Measure for Hemocompatibility Assessment of Cardiovascular Materials

    F2901-13 Standard Guide for Selecting Tests to Evaluate Potential Neurotoxicity of Medical Devices

    0 matching Proposed New Standards under the jurisdiction of F04.16     F04 Home

    Showing Results 1-10 of 10 matching WITHDRAWN standards under the jurisdiction of F04.16     F04 Home

    E1202-87(2008) Standard Guide for Development of Micronucleus Assay Standards (Withdrawn 2013)

    E1263-97(2008) Standard Guide for Conduct of Micronucleus Assays in Mammalian Bone Marrow Erythrocytes (Withdrawn 2015)

    E1280-97(2008) Standard Guide for Performing the Mouse Lymphoma Assay for Mammalian Cell Mutagenicity (Withdrawn 2015)

    E1397-91(2008) Standard Practice for In Vitro Rat Hepatocyte DNA Repair Assay (Withdrawn 2014)

    E1398-91(2008) Standard Practice for In Vivo Rat Hepatocyte DNA Repair Assay (Withdrawn 2014)

    F1905-98(2003) Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity (Withdrawn 2011)

    F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration (Withdrawn 2011)

    F2065-00(2010) Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)

    F2151-01 Standard Practice for Assessment of White Blood Cell Morphology After Contact with Materials (Withdrawn 2007)

    F2567-06(2010) Standard Practice for Testing for Classical Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)